322 related articles for article (PubMed ID: 3015406)
21. Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma.
Johnson RE; Canellos GP; Young RC; Chabner BA; DeVita VT
Cancer Treat Rep; 1978 Mar; 62(3):321-5. PubMed ID: 580598
[TBL] [Abstract][Full Text] [Related]
22. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
23. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
[TBL] [Abstract][Full Text] [Related]
24. Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group Study 822.
Doering EJ; Nitschke R; Haggard ME; Land VJ; Morgan SK; Starling K; Williams T; George S
Cancer Treat Rep; 1979 Aug; 63(8):1383-4. PubMed ID: 476711
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
Elias L; Portlock CS; Rosenberg SA
Cancer; 1978 Oct; 42(4):1705-10. PubMed ID: 361209
[TBL] [Abstract][Full Text] [Related]
26. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
[TBL] [Abstract][Full Text] [Related]
28. Immuno-chemotherapy of malignant lymphoma using OK-432, a streptococcal agent.
Kimura I; Ohnoshi T; Nakata Y; Takasugi K; Fujii M; Hayashi K; Kataoka M; Sato M; Nishihara R
Acta Med Okayama; 1979 Dec; 33(6):471-8. PubMed ID: 94239
[TBL] [Abstract][Full Text] [Related]
29. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
[TBL] [Abstract][Full Text] [Related]
30. [O.E.R.T.C. study on the treatment of non-Hodgkin's lymphomas: origin-aims-means (author's transl)].
Le Bourgeois JP
Strahlentherapie; 1977 May; 153(5):304-7. PubMed ID: 327623
[TBL] [Abstract][Full Text] [Related]
31. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens.
Cabanillas F; Rodriguez V; Freireich EJ
Med Pediatr Oncol; 1978; 4(4):321-31. PubMed ID: 364284
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle agents and cyclophosphamide in the treatment of diffuse histiocytic lymphoma.
Gomez GA; Stutzman L
Eur J Cancer (1965); 1978 Oct; 14(10):1051-5. PubMed ID: 361413
[No Abstract] [Full Text] [Related]
33. Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment.
Rodriguez V; McCredie KB; Keating MJ; Valdivieso M; Bodey GP; Freireich EJ
Cancer Treat Rep; 1978 Apr; 62(4):493-7. PubMed ID: 350386
[TBL] [Abstract][Full Text] [Related]
34. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Alexander S; Kraveka JM; Weitzman S; Lowe E; Smith L; Lynch JC; Chang M; Kinney MC; Perkins SL; Laver J; Gross TG; Weinstein H
Pediatr Blood Cancer; 2014 Dec; 61(12):2236-42. PubMed ID: 25156886
[TBL] [Abstract][Full Text] [Related]
35. Total-body irradiation in the treatment of lymphocytic lymphoma.
Chaffey JT; Hellman S; Rosenthal DS; Moloney WC
Cancer Treat Rep; 1977 Sep; 61(6):1149-52. PubMed ID: 332348
[TBL] [Abstract][Full Text] [Related]
36. Mycosis fungoides with pulmonary involvement. A complete remission.
Stein RS
Arch Dermatol; 1978 Feb; 114(2):247-9. PubMed ID: 305231
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acute non-lymphoid leukemias: comparison of two protocols.
Hauptmann E; Stacher A; Heinz R; Jaksic B
Osterr Z Onkol; 1977 Dec; 4(4):80-2. PubMed ID: 271937
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Skarin AT; Rosenthal DS; Moloney WC; Frei E
Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
[TBL] [Abstract][Full Text] [Related]
39. Diffuse histiocytic lymphoma. The need for aggressive restaging.
Weinerman BH; Levitt M; Babick T
JAMA; 1977 May; 237(22):2403-4. PubMed ID: 323527
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma.
Armitage JO; Dick FR; Platz CE; Corder MP; Leimert JT
Am J Med; 1979 Dec; 67(6):929-34. PubMed ID: 391039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
